Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society最新文献

筛选
英文 中文
In the vein of silent stasis: Weighing thrombotic risk in living liver donors. 静止静脉:衡量活体肝脏供者血栓形成的风险。
IF 3.9
Umang Arora, Saurav Panda, Robert D McBane, Danielle M Tholey, Matthew R Kappus, Kymberly D Watt
{"title":"In the vein of silent stasis: Weighing thrombotic risk in living liver donors.","authors":"Umang Arora, Saurav Panda, Robert D McBane, Danielle M Tholey, Matthew R Kappus, Kymberly D Watt","doi":"10.1097/LVT.0000000000000993","DOIUrl":"https://doi.org/10.1097/LVT.0000000000000993","url":null,"abstract":"<p><p>Thrombophilic states in the setting of living donor liver transplantation raises concerns regarding perioperative thromboembolism in the donor, as well as the potential transfer of inherited prothrombotic tendencies through mutated, hepatically synthesised coagulation factors. Screening practices for thrombophilia remain heterogeneous across centers and may result in donor exclusion based on local policies. However, accumulating evidence over the past decade suggests that most prospective donors are asymptomatic, and those with heterozygous inherited thrombophilias-such as Factor V Leiden or Prothrombin G20210A mutation-can safely undergo donation with standard perioperative thromboprophylaxis for recipient and donors. These states are unlikely to be transmitted to the recipient, as extrahepatic synthesis of coagulation proteins contributes to maintaining hemostatic balance. In contrast, donors with a prior history of thromboembolism, high-risk genotypes (e.g., homozygous or compound heterozygous states), or high-risk acquired thrombophilias should generally be excluded owing to an increased risk of thrombotic complications.</p>","PeriodicalId":520704,"journal":{"name":"Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society","volume":" ","pages":""},"PeriodicalIF":3.9,"publicationDate":"2026-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148890096","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to the Editor: Do latent-factor-derived weight trajectories after liver transplantation reflect true biological states or modeling-induced structure? 致编辑的信:肝移植后潜在因子衍生的体重轨迹是否反映了真实的生物状态或模型诱导的结构?
IF 3.9
Lingyi Meng, Haoyun Zhang
{"title":"Letter to the Editor: Do latent-factor-derived weight trajectories after liver transplantation reflect true biological states or modeling-induced structure?","authors":"Lingyi Meng, Haoyun Zhang","doi":"10.1097/LVT.0000000000000990","DOIUrl":"https://doi.org/10.1097/LVT.0000000000000990","url":null,"abstract":"","PeriodicalId":520704,"journal":{"name":"Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society","volume":" ","pages":""},"PeriodicalIF":3.9,"publicationDate":"2026-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148890138","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Should parenchymal quality inform resection decisions in non-cirrhotic HCC? a reason to consider transplant, But Not to Wait. 非肝硬化肝细胞癌的实质质量是否应作为切除决定的依据?一个考虑移植的理由,但不能等待。
IF 3.9
Dominic Amara, Vatche G Agopian
{"title":"Should parenchymal quality inform resection decisions in non-cirrhotic HCC? a reason to consider transplant, But Not to Wait.","authors":"Dominic Amara, Vatche G Agopian","doi":"10.1097/LVT.0000000000000988","DOIUrl":"https://doi.org/10.1097/LVT.0000000000000988","url":null,"abstract":"","PeriodicalId":520704,"journal":{"name":"Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society","volume":" ","pages":""},"PeriodicalIF":3.9,"publicationDate":"2026-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148890102","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply: Do latent-factor-derived weight trajectories after liver transplantation reflect true biological states or modeling-induced structure? 回复:肝移植后潜在因子衍生的体重轨迹反映的是真实的生物状态还是模型诱导的结构?
IF 3.9
Alexis Kim, Mohammad Shadab Siddiqui, Anh T Bui
{"title":"Reply: Do latent-factor-derived weight trajectories after liver transplantation reflect true biological states or modeling-induced structure?","authors":"Alexis Kim, Mohammad Shadab Siddiqui, Anh T Bui","doi":"10.1097/LVT.0000000000000992","DOIUrl":"https://doi.org/10.1097/LVT.0000000000000992","url":null,"abstract":"","PeriodicalId":520704,"journal":{"name":"Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society","volume":" ","pages":""},"PeriodicalIF":3.9,"publicationDate":"2026-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148890172","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to the Editor: Safe use of living donor right liver graft with dual portal veins. 致编辑的信:双门静脉右肝移植的安全使用。
IF 3.9
Sorabh Kapoor
{"title":"Letter to the Editor: Safe use of living donor right liver graft with dual portal veins.","authors":"Sorabh Kapoor","doi":"10.1097/LVT.0000000000000876","DOIUrl":"10.1097/LVT.0000000000000876","url":null,"abstract":"","PeriodicalId":520704,"journal":{"name":"Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society","volume":" ","pages":"E65-E66"},"PeriodicalIF":3.9,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147680208","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to the Editor: One size does not fit all-Reconstructing multiple bile ducts in right lobe liver transplantation. 致编辑的信:一种方法并不适合所有人——在右叶肝移植中重建多个胆管。
IF 3.9
Sorabh Kapoor
{"title":"Letter to the Editor: One size does not fit all-Reconstructing multiple bile ducts in right lobe liver transplantation.","authors":"Sorabh Kapoor","doi":"10.1097/LVT.0000000000000884","DOIUrl":"10.1097/LVT.0000000000000884","url":null,"abstract":"","PeriodicalId":520704,"journal":{"name":"Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society","volume":" ","pages":"E73-E74"},"PeriodicalIF":3.9,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147719358","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Geographic and structural variability in liver transplant outreach programs: A national survey of academic centers. 肝移植外展项目的地理和结构差异:一项全国学术中心调查。
IF 3.9
James L Rogers, Rahul Mohan, Avash Kalra
{"title":"Geographic and structural variability in liver transplant outreach programs: A national survey of academic centers.","authors":"James L Rogers, Rahul Mohan, Avash Kalra","doi":"10.1097/LVT.0000000000000867","DOIUrl":"10.1097/LVT.0000000000000867","url":null,"abstract":"","PeriodicalId":520704,"journal":{"name":"Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society","volume":" ","pages":"1335-1339"},"PeriodicalIF":3.9,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13480314/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147535407","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical outcomes after liver transplantation using donor grafts with SERPINA1 Z heterozygosity. SERPINA1 Z杂合性供体肝移植后的临床结果。
IF 3.9
Fredrik Åberg, Maria Semenova, Ville Liukkonen, Jukka Partanen, Kati Hyvärinen, Arno Nordin
{"title":"Clinical outcomes after liver transplantation using donor grafts with SERPINA1 Z heterozygosity.","authors":"Fredrik Åberg, Maria Semenova, Ville Liukkonen, Jukka Partanen, Kati Hyvärinen, Arno Nordin","doi":"10.1097/LVT.0000000000000878","DOIUrl":"10.1097/LVT.0000000000000878","url":null,"abstract":"","PeriodicalId":520704,"journal":{"name":"Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society","volume":" ","pages":"1340-1342"},"PeriodicalIF":3.9,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13480318/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147680236","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beyond rejection risk: Identifying ideal candidates for pretransplant immune checkpoint inhibitors for HCC. 超越排斥风险:确定肝细胞癌移植前免疫检查点抑制剂的理想候选药物
IF 3.9
Laia Aceituno, Grainne M O'Kane, Woo Jin Choi, Parissa Tarbizian, Roxana Bucur, Nadia Rukavina, Anudari Zorigtbaatar, Beatriz Mínguez, Arndt Vogel, Gonzalo Sapisochin
{"title":"Beyond rejection risk: Identifying ideal candidates for pretransplant immune checkpoint inhibitors for HCC.","authors":"Laia Aceituno, Grainne M O'Kane, Woo Jin Choi, Parissa Tarbizian, Roxana Bucur, Nadia Rukavina, Anudari Zorigtbaatar, Beatriz Mínguez, Arndt Vogel, Gonzalo Sapisochin","doi":"10.1097/LVT.0000000000000829","DOIUrl":"10.1097/LVT.0000000000000829","url":null,"abstract":"<p><p>The role of immune checkpoint inhibitors (ICIs) before liver transplantation (LT) for HCC remains uncertain. In particular, the optimal treatment duration and the potential long-term oncologic benefits remain unclear. Thus, we conducted a systematic review to evaluate outcomes of ICI as bridging or downstaging therapy before LT. Following PRISMA guidelines (PROSPERO CRD1082620), 5 databases were systematically searched up to March 2025. All published studies reporting ICI before LT in HCC were included. Data were synthesized descriptively, and exploratory regression models, including restricted cubic splines, were performed. Thirty-nine studies comprising 261 patients were included. Most were male (87.3%), over 50 years old, and had viral hepatitis as the predominant etiology of their liver disease. ICIs were mainly used for downstaging (84.2%), most frequently using nivolumab (24.5%). The median ICI duration was 63 days (42-105), with a median washout period of 57 days (29-116). Most patients presented with multifocal disease (77.9%) and tumors beyond Milan criteria, with a median largest lesion size of 37.5 mm (9.4-78.5). Macrovascular invasion was present in 15.7%. Posttransplant recurrence occurred in 18.6%. Shorter ICI exposure was significantly associated with a higher risk of recurrence (OR: 0.9; p <0.001). Spline models demonstrated that the benefit of ICI treatment was achieved at 80 days. Paradoxically, patients with BCLC A exhibited higher recurrence risk (OR: 5.2; p =0.01), perhaps underscoring the limitations of conventional staging in candidate selection. Allograft rejection occurred in 23.0% of patients and led to graft failure in 14.7%. Younger age (<50 y) and a shorter washout period (<50 d) were independently associated with an increased risk of recurrence and rejection, respectively. The duration of ICI treatment before LT is a critical factor influencing HCC recurrence risk, with an optimal treatment duration of more than 80 days. Furthermore, a confirmatory washout period of at least 50 days appears to be important to mitigate the risk of rejection.</p>","PeriodicalId":520704,"journal":{"name":"Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society","volume":" ","pages":"1285-1296"},"PeriodicalIF":3.9,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13480327/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147489318","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
When the tide recedes: From portal relief to fascial grief. 当潮水退去:从门静脉缓解到筋膜悲伤。
IF 3.9
Xiaohan Ying, Brett E Fortune
{"title":"When the tide recedes: From portal relief to fascial grief.","authors":"Xiaohan Ying, Brett E Fortune","doi":"10.1097/LVT.0000000000000859","DOIUrl":"10.1097/LVT.0000000000000859","url":null,"abstract":"","PeriodicalId":520704,"journal":{"name":"Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society","volume":" ","pages":"1227-1229"},"PeriodicalIF":3.9,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147518297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书